Gliptus 50 Mg 30 Capsules

Gliptus 50 Mg 30 Capsules

Description:

Gliptus 50 mg 30 capsules is an oral anti-diabetic prescription medicine containing vildagliptin, a dipeptidyl peptidase-4 (dpp-4) inhibitor. It is used as part of a comprehensive diabetes care plan to help control blood glucose levels in adults with type 2 diabetes mellitus. Gliptus works by increasing the levels of incretin hormones, which enhance insulin secretion and reduce glucagon release in a glucose-dependent manner, thereby improving glycemic control without usually causing weight gain. It is typically used in combination with diet, exercise, and sometimes other anti-diabetic medications as directed by a healthcare professional.

Indications:

• Management of type 2 diabetes mellitus in adults to improve glycemic control.
• May be used as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance or contraindications (as per physician’s judgment).
• Adjunctive therapy in combination with other oral anti-diabetic agents (such as metformin, sulfonylureas, thiazolidinediones, or insulin) when these, together with diet and exercise, do not provide adequate glycemic control.
• Helps reduce elevated fasting and postprandial blood glucose levels.
• Supports long-term diabetes management to help reduce the risk of diabetes-related complications when used as part of a comprehensive treatment plan.

Active Ingredients / Key Components:

• Vildagliptin – 50 mg per capsule.
• Excipients: Information on inactive ingredients (capsule shell components, fillers, stabilizers, colorants) is not available in the provided data. Please refer to the official package leaflet for the complete excipient list.

Dosage & Administration / How to Use:

• The exact dose and regimen must always be determined by the treating physician based on the patient’s clinical condition, kidney function, and concomitant medications.
• Typical adult dose in many treatment protocols: vildagliptin 50 mg once or twice daily, either as monotherapy or in combination with other anti-diabetic agents. However, follow only your doctor’s specific instructions.
• Swallow the capsule whole with a glass of water. Do not crush, chew, or open the capsule unless your doctor or pharmacist specifically advises otherwise.
• Gliptus 50 mg capsules may be taken with or without food, preferably at the same time(s) each day to maintain consistent blood levels.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not take a double dose to make up for a missed one.
• Use in elderly patients or those with renal or hepatic impairment may require dose adjustment or special monitoring; this must be decided by a healthcare professional.
• Continue taking this medicine regularly even if you feel well, and do not stop or change the dose without consulting your doctor.

Clinical Benefits:

• Improves glycemic control in adults with type 2 diabetes by enhancing glucose-dependent insulin secretion and decreasing glucagon levels.
• Helps reduce both fasting and postprandial blood glucose, contributing to better overall blood sugar stability.
• Low intrinsic risk of hypoglycemia when used as monotherapy, due to its glucose-dependent mechanism of action (risk may increase when combined with sulfonylureas or insulin).
• Generally weight-neutral, making it suitable for many patients concerned about weight gain associated with some other anti-diabetic therapies.
• Can be combined with other oral anti-diabetic agents or insulin to achieve individualized treatment goals when monotherapy is insufficient.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to vildagliptin or any of the excipients in the formulation.
• Not indicated for use in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
• Use with caution in patients with moderate to severe renal impairment; dose adjustment and close monitoring may be required as per physician guidance.
• Use with caution in patients with hepatic impairment or elevated liver enzymes; periodic monitoring of liver function tests may be recommended.
• Reports of pancreatitis have been associated with dpp-4 inhibitors. Patients should be informed of the characteristic symptoms of acute pancreatitis (such as persistent, severe abdominal pain) and advised to seek immediate medical attention if they occur.
• Hypoglycemia risk increases when vildagliptin is used in combination with sulfonylureas or insulin; dose adjustment of the concomitant agent may be necessary.
• Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding. The safety of vildagliptin in pregnancy and lactation has not been fully established; your doctor will decide whether to use this medicine based on benefit–risk assessment.
• Inform your doctor about all other medications you are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.
• Patients with a history of heart failure, pancreatitis, or severe gastrointestinal disease should use this medicine only under strict medical supervision.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, dizziness, mild gastrointestinal disturbances (such as nausea, abdominal discomfort, constipation), and fatigue.
• When used in combination with other anti-diabetic agents (especially sulfonylureas or insulin), hypoglycemia (low blood sugar) may occur. Symptoms include sweating, tremor, hunger, confusion, palpitations, and dizziness.
• Less common but potentially serious side effects may include pancreatitis (severe, persistent abdominal pain that may radiate to the back, with or without vomiting), liver enzyme elevations, or hypersensitivity reactions (rash, itching, swelling, difficulty breathing).
• Stop taking the medicine and seek immediate medical attention if you experience signs of severe allergic reaction, severe abdominal pain, yellowing of the skin or eyes (jaundice), dark urine, or unexplained persistent fatigue.
• This is not a complete list of side effects. For full safety information, refer to the official patient leaflet and consult your healthcare provider.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the container tightly closed and store at or below the temperature specified on the outer packaging (exact temperature range is not available in the provided data; refer to the product carton). Do not use after the expiry date printed on the pack. Keep out of reach of children.

Specifications:

• Product type: Prescription anti-diabetic medicine (oral).
• Active ingredient strength: vildagliptin 50 mg per capsule.
• Form: Capsules for oral administration.
• Pack size: 30 capsules per pack.
• Intended use: Adult patients with type 2 diabetes mellitus, as prescribed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.